External Source

Oral Combo For Newly Diagnosed Older Adults With Acute Myeloid Leukemia | Gabriel Mannis | Ash 2021

2022 3:42
Synopsis
Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track ...

You Might Also Like

Dr. Mannis Talks About Emerging Treatments for Acute Myeloid Leukemia 1:22
Dr. Mannis Talks About Emerging Treatments For Acute Myeloid...
2018
Treating Acute Myeloid Leukemia (AML) in Older Adults 52:41
Treating Acute Myeloid Leukemia (aml) In Older Adults
2023
Dr. Mannis on the Application of Gemtuzumab Ozogamicin in Patients With AML 1:01
Dr. Mannis On The Application Of Gemtuzumab Ozogamicin In Pa...
2018
Dr. Gabriel Mannis Shares TUSCANY Trial Results of Tuspetinib Triplet in AML 8:19
Dr. Gabriel Mannis Shares Tuscany Trial Results Of Tuspetini...
2025
Dr. Mannis on Targeted Agents in the Treatment of Patients With AML 1:16
Dr. Mannis On Targeted Agents In The Treatment Of Patients W...
2018
Treating AML with BCL-2 inhibitors 1:49
Treating Aml With Bcl-2 Inhibitors
2020
Long-term OS with oral azacitidine in patients with acute myeloid leukaemia in first remission a... 4:59
Long-term Os With Oral Azacitidine In Patients With Acute My...
2022
Management of Older Adults with AML - J. Zeidner - 20250416 57:05
Management Of Older Adults With Aml - J. Zeidner - 20250416
2025
Enasidenib plus Azacitidine Combination Therapy for Acute Myeloid Leukaemia 4:55
Enasidenib Plus Azacitidine Combination Therapy For Acute My...
2021
Rationale of OMNIVERSE: oral azacitidine + venetoclax in patients with R/R or newly diagnosed AML 1:51
Rationale Of Omniverse: Oral Azacitidine + Venetoclax In Pat...
2022
Factors That Impact Treatment Decisions in Elderly Individuals With AML 6:32
Factors That Impact Treatment Decisions In Elderly Individua...
2021
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.